We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

281 hedge funds and large institutions have $7.27B invested in PHARMACYCLICS INC in 2014 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 95 increasing their positions, 93 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 19

12% more funds holding

Funds holding: 250281 (+31)

8% more capital invested

Capital invested by funds: $6.76B → $7.27B (+$515M)

2% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 93

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

24% less call options, than puts

Call options by funds: $100M | Put options by funds: $132M

Holders
281
Holders Change
+31
Holders Change %
+12.4%
% of All Funds
7.5%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.21%
New
53
Increased
95
Reduced
93
Closed
19
Calls
$100M
Puts
$132M
Net Calls
-$32.4M
Net Calls Change
+$71.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
51
Wells Fargo
California
$12.5M +$7.91M +61,886 +153%
Charles Schwab
52
Charles Schwab
California
$12.1M +$653K +5,110 +5%
MSA
53
Mason Street Advisors
Wisconsin
$12M +$1.15M +9,000 +10%
GC
54
Guggenheim Capital
Illinois
$11.7M +$1.46M +11,435 +14%
Invesco
55
Invesco
Georgia
$11.3M -$9.32M -72,931 -44%
SCM
56
Suffolk Capital Management
New York
$11.1M -$1.67M -13,081 -13%
State Board of Administration of Florida Retirement System
57
State Board of Administration of Florida Retirement System
Florida
$11M -$257K -2,013 -2%
RSCM
58
Rock Springs Capital Management
Maryland
$10.8M +$415K +3,250 +4%
OM
59
Opaleye Management
Massachusetts
$10.4M
MTB
60
Mizuho Trust & Banking
Japan
$10.1M +$785K +6,144 +8%
EAM
61
Eventide Asset Management
Massachusetts
$10.1M
ORI
62
Oak Ridge Investments
Illinois
$9.96M -$330K -2,580 -3%
BJ
63
BlackRock Japan
Japan
$9.92M +$1.07M +8,392 +12%
CC
64
Curian Capital
Colorado
$9.67M +$721K +5,644 +8%
PAM
65
Panagora Asset Management
Massachusetts
$9.61M -$7.23M -56,554 -42%
APG Asset Management
66
APG Asset Management
Netherlands
$9.11M -$709K -5,546 -7%
PC
67
PointState Capital
New York
$9.07M +$9.48M +74,150 New
Prudential Financial
68
Prudential Financial
New Jersey
$8.59M +$7.27M +56,900 +426%
Fuller & Thaler Asset Management
69
Fuller & Thaler Asset Management
California
$7.87M +$128K +1,000 +2%
AQR Capital Management
70
AQR Capital Management
Connecticut
$7.77M +$6.66M +52,100 +455%
TAM
71
Tocqueville Asset Management
New York
$7.68M -$990K -7,750 -11%
Macquarie Group
72
Macquarie Group
Australia
$7.4M -$262K -2,050 -3%
WBC
73
Westpac Banking Corp
Australia
$7.34M +$7.16M +56,000 +1,389%
Swiss National Bank
74
Swiss National Bank
Switzerland
$7.21M -$268K -2,100 -3%
AL
75
Airain Ltd
Guernsey
$7.19M +$7.51M +58,797 New

PCYC Hedge Fund Activity: Q4 2014 in Review

281 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q4 2014, worth a combined $7.27B — up 7.6% from $6.76B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new PCYC positions and 19 closed out — a net gain of 34 holders — while 95 added to existing stakes and 93 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $136M. The largest seller was Baker Bros. Advisors, cutting an estimated $67.4M.

  • 281 institutional investors held PHARMACYCLICS INC (PCYC) as of Q4 2014, up from 250 in Q3 2014.
  • Funds reported $7.27B of PHARMACYCLICS INC stock for Q4 2014, up 7.6% quarter-over-quarter.
  • 53 funds opened new PHARMACYCLICS INC positions in Q4 2014 and 19 closed out, a net change of +34 holders.
  • The largest PHARMACYCLICS INC buyer in Q4 2014 was Janus Henderson Investors US, an estimated $136M added.
  • The largest PHARMACYCLICS INC seller in Q4 2014 was Baker Bros. Advisors, an estimated $67.4M sold.

Based on aggregated 13F filings for Q4 2014.